Induction of Molecular Chaperones as a Therapeutic Strategy for the Polyglutamine Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|11|2|188-197

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.11, Iss.2, 2010-02, pp. : 188-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transcriptional Dysregulation: A Therapeutic Target for Polyglutamine Diseases

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 2, 2005-06 ,pp. : 119-127

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide-Based Therapeutic Approaches for Treatment of the Polyglutamine Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2575-2582

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic applications of heat shock proteins and molecular chaperones

By Clark John I  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. : 1153-1160

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Approaches to Polyglutamine Diseases: Combating Protein Misfolding and Aggregation

By  

Current Pharmaceutical Design, Vol. 12, Iss. 20, 2006-07 ,pp. : 2543-2555

Bentham Science Publishers

Access to resources Recommend Favorite

Conformational Changes and Aggregation of Expanded Polyglutamine Proteins as Therapeutic Targets of the Polyglutamine Diseases: Exposed &bgr;-Sheet Hypothesis

By  

Current Pharmaceutical Design, Vol. 14, Iss. 30, 2008-10 ,pp. : 3267-3279

Bentham Science Publishers

Access to resources Recommend Favorite